Theyre not recommended if you have: Gastroparesis or severe GI conditions A personal or family history of medullary thyroid carcinoma or MEN2 genetic syndrome A history of pancreatitis Pregnancy or are breastfeeding Diabetic retinopathy (risk of worsening with rapid glucose drops) Always share your full health history with your providertransparency is critical for safe recommendations
Store the unopened lyophilized vial in a cool, dry place between 2-8 C, protected from light
matches Phase 3 retatrutide cadence Cycle driver CJC/Ipa cycled 12 weeks on / 4 weeks off Retatrutide Loading 2 mg/week (weeks 1-4) Frequency 1x weekly Maintenance 9-12 mg/week (weeks 17-20+) Route SubQ
By pairing medication with patient-first care, employers can improve long-term outcomes, adherence, and potentially reduce reliance on expensive drugs over time
Although there is no GLP-1RA approved for the treatment of AS, these findings could provide novel approaches for the treatment of AS
The takeaway: Compounded pharmacies offer more affordable options for GLP-1 drugs, but there are increased risks that result in a "buyer-beware" market